Partner Joe Jacquot was quoted in an American Banker article, “As Uncertainty Swirls, CFPB Keeps on Regulating,” explaining why banks cannot ignore the Consumer Financial Protection Bureau’s recently released semiannual report because of possible CFPB leadership changes.
Even though CFPB Director Richard Cordray is rumored to be leaving the agency, Jacquot said banks still need to review the semiannual report because it forecasts specific issues that the CFPB is focused on based on the past six months of supervisory exams.
Jacquot explained: “It would be at your own peril to ignore [the issues identified within the report], because whether Cordray stays or Trump decides to go with someone [to replace him], the priorities are indicative of where the agency may go.” The report contains “the kind of information state attorneys general offices will mine to begin to develop cases.”
Read the full article here (subscription required).
Even though CFPB Director Richard Cordray is rumored to be leaving the agency, Jacquot said banks still need to review the semiannual report because it forecasts specific issues that the CFPB is focused on based on the past six months of supervisory exams.
Jacquot explained: “It would be at your own peril to ignore [the issues identified within the report], because whether Cordray stays or Trump decides to go with someone [to replace him], the priorities are indicative of where the agency may go.” The report contains “the kind of information state attorneys general offices will mine to begin to develop cases.”
Read the full article here (subscription required).
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”